Achieve Life Sciences Competitors and Similar CompaniesClear all

Achieve Life Sciences's competitors and similar companies include Iterion Therapeutics, Memgen, United Therapeutics and Ayala Pharmaceuticals.

	Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.	Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics.	Memgen Memgen is a clinical-stage biotechnology company.	United Therapeutics United Therapeutics Corporation is a company that develops products for chronic and life-threatening disease treatment.	Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
Founding Date	Founding Date 1995	Founding Date 2014	Founding Date 2004	Founding Date 1996	Founding Date 2017
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development life sciences oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development life sciences oncology pharma therapy
Locations	Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US	Locations Houston, US HQ	Locations Houston, US HQ	Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US	Locations Wilmington, US HQ Rehovot, IL Wilmington, US
Employees	Employees 148% increase	Employees 176% increase	Employees 7	Employees 1,16819% increase	Employees 29
Valuation ($)	Valuation ($) 166.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 15.7 b	Valuation ($) 7.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.9b (FY, 2024)	Revenue (est.) $692k (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $309.7m (FY, 2024)	Cost of goods $602k (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $2.6b (FY, 2024)	Gross profit $90k (FY, 2022)
Net income	Net income ($39.8m) (FY, 2024)	Net income N/A	Net income N/A	Net income $1.2b (FY, 2024)	Net income ($38m) (FY, 2022)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 2.6m (almost 7 years ago)	Latest funding round $ 865k (over 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 10m	Total funding raised $ 4.4m	Total funding raised $ 8.5m	Total funding raised N/A	Total funding raised $ 47m